1
Better Coronavirus Stock: BioNTech or Vir Biotechnology?
Research topic
2
BioNTech to Acquire GMP Manufacturing Site to Expand COVID-19 Vaccine Production Capacity in First Half 2021
Research topic
3
Pfizer urged to hold off on coronavirus vaccine until late November: report
Research topic
4
Pfizer, BioNTech 'quietly' usher a 5th COVID-19 jab into the clinic: analyst
Research topic
5
Pfizer and BioNTech Propose Expansion of Pivotal COVID-19 Vaccine Trial
Research topic
6
Pfizer and BioNTech To Supply Qatar With Their bnt162 Mrna-Based Vaccine Candidate Against Sars-Cov-2
Research topic
7
BioNTech to Receive up to €375M in Funding from German Federal Ministry of Education and Research to Support COVID-19 Vaccine Program BNT162
Research topic
8
Pfizer, BioNTech report 'strong' immune response in animals to COVID-19 mRNA vaccine candidate
Research topic
9
Pfizer partner BioNTech sees no role for its vaccine in UK challenge trial
Research topic
10
Pfizer, BioNTech Inch Closer to COVID-19 Vax Deal with EU
Research topic
11
Pfizer and BioNTech Announce Data from Preclinical Studies of mRNA-based Vaccine Candidate Against COVID-19
Research topic
12
Moderna, BioNTech, Pfizer stocks rally after AstraZeneca COVID-19 vaccine trial is reportedly halted
Research topic
13
Why BioNTech Stock Is Falling Today
Research topic
14
Is BioNTech's Coronavirus Vaccine Candidate a Game-Changer for Investors?
Research topic
15
Pfizer/BioNTech COVID-19 vaccine candidate shows encouraging action in preclinical studies
Research topic
16
BioNTech Stock Boosted by COVID-19 Vaccine Pact
Research topic
17
Where the 4 major coronavirus vaccine candidates currently stand
Research topic
18
4 Coronavirus Vaccine Stocks the Bill & Melinda Gates Foundation Is Betting On
Research topic
19
Covid-19 Vaccine Update: Inovio Stock Tumbles After Trial Is Halted
Research topic
20
Covid-19 roundup: Fauci reiterates October vaccine OK 'unlikely'; Pfizer and BioNTech reserve 200M doses for EU
Research topic
21
Vaccine could be ready for approval by October, CEO says
Research topic
22
Navajo Nation to participate in Pfizer-BioNTech COVID-19 vaccine trial
Research topic
23
Pfizer and BioNTech may know before rivals about Covid vaccine shot
Research topic
24
BioNTech Investor Fortunes Rise and Fall on Headlines, Pacts and Funding
Research topic
25
Moderna or BioNTech: J.P. Morgan Lays Odds On the Race to a COVID-19 Vaccine
Research topic
26
BioNTech, Bayer, Valeo Pharma: Share price jump ahead of quarterly results
Research topic
27
Shanghai Fosun Pharma, Sinopharm Group sign deal to supply BioNTech coronavirus vaccine candidate
Research topic
28
The Daily Biotech Pulse: Moderna Inks 2 R&D Deals, BioNTech To Buy Manufacturing Facility, Dyne Therapeutics IPO
Research topic
29
Reality Check For COVID Vaccines: Caution Moderna, BioNTech, Novavax
Research topic
30
BRIEF-Pfizer And Biontech Propose Expansion Of Pivotal Covid-19 Vaccine Trial
Research topic
31
J.P. Morgan Stick to Their Hold Rating for BioNTech SE
Research topic
32
Are Investors Keen On Selling Holdings In BioNTech SE (NASDAQ:BNTX)?
Research topic
33
Pfizer, BioNTech Seek to Expand Enrollment of Vaccine Trial
Research topic
34
BioNTech Buys German Factory to Boost Covid Vaccine Capacity
Research topic
35
Under pressure, Pfizer, Moderna (and soon AstraZeneca) publish COVID-19 vaccine protocols
Research topic
36
BNTX Stock, NVAX Stock Up As Covid-19 Vaccine Efforts Advance
Research topic
37
There are four coronavirus vaccines in late-stage studies — here’s how they differ
Research topic
38
BioNTech shares are trading higher, not currently seeing company-specific news from the session. Strength potentially related to continued vaccine interest as coronavirus concerns grow going into the fall.
Research topic
39
Here is a bargain stock you should look at : BioNTech SE (BNTX)
Research topic
40
Fosun/BioNTech could supply Macau and HK with 10 mln Covid-19 vaccine doses
Research topic
41
BioNTech makes a deal with Novartis
Research topic
42
mRNA Therapy Market Size is Thriving Worldwide with Topmost Companies Like:Moderna, BioNTech, Pfizer, Arcturus Therapeutics Holdings Inc., Astrazeneca, CureVac
Research topic
43
3 Top Biotech Stocks to Buy Right Now
Research topic
44
COVID-19 Clinical Trials Market will touch a new level in upcoming year with Top Key Players like INOVIO Pharmaceuticals, AbbVie Inc., BioNTech SE, Novavax, Takeda
Research topic
45
If You Invested $1,000 in Inovio Pharmaceuticals in January, This Is How Much You'd Have Now
Research topic
46
Adding $500 to These 3 Top Stocks Would Be a Brilliant Move
Research topic
47
Global mRNA Cancer Vaccines and Therapeutics Market Outlook 2020-2026 : Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics
Research topic
48
Sell Moderna Stock, Analyst Says, Because Covid Vaccine Competition Is Fierce
Research topic
49
Many Iowans plan to wait on taking coronavirus vaccine: poll
Research topic
50
Pfizer and BioNTech Announce an Agreement with U. S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2
Research topic
51
Here's My Top Coronavirus Vaccine Stock to Buy
Research topic
52
BioNTech Publishes Data from mRNA-based BNT111 FixVac Melanoma Trial in Nature
Research topic
53
BioNTech to Hold Webcast to Present Early Positive Data from Ongoing Phase 1/2 Study of mRNA-based Vaccine Candidate Against SARS-CoV-2
Research topic
54
3 Ways to Cash In on Low Taxes While They Last
Research topic
55
BioNTech Announces Proposed Public Offerings Nasdaq:BNTX
Research topic
56
Pfizer and BioNTech Announce Early Positive Update from German Phase 1/2 COVID-19 Vaccine Study, Including First T Cell Response Data
Research topic
57
BioNTech and Pfizer announce completion of dosing for first cohort of Phase 1/2 trial of COVID-19 vaccine candidates in Germany
Research topic
58
Pfizer and BioNTech began late-stage human trial for coronavirus vaccine Monday
Research topic
59
Unprecedented Global Turmoil Underlines Need for Effective Diagnostics
Research topic
60
Pfizer and BioNTech to Supply Japan with 120 Million Doses of Their BNT162 mRNA-Based Vaccine Candidate
Research topic
61
A Second Wave of Coronavirus Could Be Coming: 3 Stocks to Buy Before It Hits
Research topic
62
Pfizer, BioNTech share clinical data linking favored COVID-19 vaccine to improved tolerability
Research topic
63
BioNTech to Raise USD 250 Million in Private Placement
Research topic
64
BioNTech Announces Closing of $512 Million Underwritten Offering of American Depositary Shares
Research topic
65
BioNTech Announces First Quarter 2020 Financial Results and Corporate Progress
Research topic
66
German Biotech Sees Its Coronavirus Vaccine Ready for Approval by December
Research topic
67
BioNTech Announces Strategic Collaboration with Regeneron to Advance FixVac and Libtayo® (cemiplimab) Combination in Melanoma
Research topic
68
BioNTech and Fosun Pharma Announce Start of Clinical Trial of mRNA-based COVID-19 Vaccine Candidate in China
Research topic
69
Here's the Bigger Story About Moderna That You Might Be Missing
Research topic
70
BioNTech Announces Second Quarter 2020 Financial Results and Corporate Progress
Research topic
71
Pfizer, BioNTech get fast-track from FDA for Covid-19 vaccines
Research topic
72
Pfizer and BioNTech to Supply Canada with their BNT162 mRNA- Based Vaccine Candidate
Research topic
73
BioNTech and Pfizer announce regulatory approval from German authority Paul-Ehrlich-Institut to commence first clinical trial of COVID-19 vaccine candidates
Research topic
74
Pfizer, BioNTech are set to begin US coronavirus vaccine trial
Research topic
75
Thinking about trading options or stock in Nikola Corp, BioNTech, Johnson & Johnson, General Electric, or Tesla?
Research topic
76
BioNTech Completes Acquisition of Neon Therapeutics Nasdaq:BNTX
Research topic
77
Rna Vaccines Market Size, Regional Insights and Industry Dynamics By 2027 | By Top Leading Vendors – Curevac, Moderna Therapeutics, Translate Bio, Biontech, Sangamo Therapeutics, Argos Therapeutics, In-cell-art
Research topic
78
Pfizer, BioNTech to ramp up COVID-19 vaccine tests, plot major trial boost in fall
Research topic
79
Pfizer and BioNTech to Co-develop Potential COVID-19 Vaccine
Research topic
80
Personalized Cancer Vaccines Market 2020-2026 is Flourishing Worldwide || Leading Players – F. Hoffmann-La Roche Ltd, CureVac AG, Celldex Therapeutics, BioNTech SE, Advaxis, Inc
Research topic
81
Personalized Cancer Vaccines Market 2020-2026 In Depth Business Growth Analysis || Leading Players – F. Hoffmann-La Roche Ltd, CureVac AG, Celldex Therapeutics, BioNTech SE, Advaxis, Inc
Research topic
82
mRNA Cancer Vaccines and Therapeutics Market Research & Clinical Advancements by 2028 | Moderna Therapeutics, eTheRNA, BioNTech
Research topic
83
Covid vaccine: Russia may be the first to announce data from final trial
Research topic
84
Moderna's Coronavirus Treatment Transforms Body Into Vaccine-Making Machine
Research topic
85
Pfizer and BioNTech Announce Further Details on Collaboration to Accelerate Global COVID-19 Vaccine Development
Research topic
86
Pfizer and BioNTech Announce Early Positive Data from an Ongoing Phase 1/2 study of mRNA-based Vaccine Candidate Against SARS-CoV-2
Research topic
87
Is BioNTech Stock a Buy?
Research topic
88
Why Is Everyone Talking About BioNTech Stock?
Research topic
89
Pfizer, BioNTech score deal to supply 120M Covid-19 vaccine doses to Japan
Research topic
90
No takeover approach, says COVID-19 vaccine developer BioNTech
Research topic
91
BioNTech to Report Second Quarter 2020 Financial Results and Operational Update on August 11, 2020
Research topic
92
Regeneron and BioNTech Partner on Immunotherapy Combo for Melanoma
Research topic
93
Pfizer and BioNTech work on coronavirus vaccine
Research topic
94
Better Coronavirus Vaccine Stock: BioNTech vs. Moderna
Research topic
95
Better Coronavirus Stock: Biogen or BioNTech?
Research topic
96
Why BioNTech Stock Vaulted Higher Today
Research topic
97
BioNTech SE (BNTX) Q2 2020 Earnings Call Transcript
Research topic
98
Why BioNTech Shares Are Falling Today
Research topic
99
BioNTech, China's Fosun to potentially supply 10 million doses of COVID-19 vaccine
Research topic
100
BioNTech SE (BNTX) Is Worth A Look Now, Despite 56.9% Loss From High
Research topic
